Kala Pharmaceuticals Inc. buy Oppenheimer Holdings Inc.
Start price
01.04.24
/
50%
€7.29
Target price
01.04.25
€13.96
Performance (%)
-12.29%
Price
02.05.24
€6.09
Summary
This prediction is currently active. The price of Kala Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.29%. This prediction currently runs until 01.04.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Kala Pharmaceuticals Inc. | 4.500% | 4.500% |
| iShares Core DAX® | 0.000% | -2.064% |
| iShares Nasdaq 100 | 0.626% | -2.884% |
| iShares Nikkei 225® | 1.568% | -5.892% |
| iShares S&P 500 | 0.334% | -2.281% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Kala Pharmaceuticals diskutieren
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Ratings data for KALA provided by MarketBeat